Rheumatoid factor secretion from human Leu-1+ B cells.

PubWeight™: 2.65‹?› | Rank: Top 1%

🔗 View Article (PMID 3105057)

Published in Science on April 03, 1987

Authors

R R Hardy, K Hayakawa, M Shimizu, K Yamasaki, T Kishimoto

Articles citing this

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol (2008) 5.24

The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol (2010) 4.26

Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest (2005) 2.40

Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology (2005) 1.89

Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. EMBO J (1988) 1.69

Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (1989) 1.66

Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice. Hum Immunol (2009) 1.53

The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstein-Barr virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. Further evidence that some autoantibodies are unmutated copies of germ line genes. J Clin Invest (1990) 1.52

Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Int Immunol (1991) 1.50

Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol (1993) 1.46

Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J Immunol (1992) 1.45

Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc Natl Acad Sci U S A (1988) 1.39

Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med (1999) 1.23

Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus. J Clin Invest (1990) 1.17

Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes. J Clin Invest (1991) 1.12

B-cell targeted therapeutics in clinical development. Arthritis Res Ther (2013) 1.09

Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconj J (1998) 1.08

A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice. Arthritis Rheum (2009) 1.07

B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med (1998) 1.06

A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. Cancer Res (2008) 1.03

Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J Exp Med (2009) 1.01

Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Clin Exp Immunol (1993) 1.01

Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients. Proc Natl Acad Sci U S A (1995) 1.00

Delineation of the functional capacity of human neonatal lymphocytes. J Clin Invest (1991) 1.00

Migration and differentiation of autoreactive B-1 cells induced by activated gamma/delta T cells in antierythrocyte immunoglobulin transgenic mice. J Exp Med (2000) 0.99

Chagas' disease is attenuated in mice lacking gamma delta T cells. Infect Immun (1996) 0.98

Human B-1 cells take the stage. Ann N Y Acad Sci (2013) 0.97

CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation. Proc Natl Acad Sci U S A (2001) 0.96

How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth. Immunol Rev (2013) 0.96

VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J Immunol (1997) 0.95

Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection. PLoS One (2010) 0.94

Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem J (1996) 0.93

B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol (1990) 0.92

Immunoglobulin and cytokine production by neonatal lymphocytes. Clin Exp Immunol (1991) 0.92

Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol (2002) 0.92

Role of PIR-B in autoimmune glomerulonephritis. J Biomed Biotechnol (2010) 0.91

Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies. Am J Pathol (1990) 0.91

Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol (1997) 0.91

CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies. Am J Pathol (1990) 0.90

CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40. Immunology (2000) 0.89

Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus. J Clin Invest (1989) 0.87

B cells: the old new players in reproductive immunology. Front Immunol (2014) 0.87

VH3-21 B cells escape from a state of tolerance in rheumatoid arthritis and secrete rheumatoid factor. Mol Med (1995) 0.87

Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis. J Immunol (1998) 0.86

Association of in utero sensitization to Schistosoma haematobium with enhanced cord blood IgE and increased frequencies of CD5- B cells in African newborns. Am J Trop Med Hyg (2012) 0.86

B lymphocyte intestinal homing in inflammatory bowel disease. BMC Immunol (2011) 0.84

Selective induction of rheumatoid factors by superantigens and human helper T cells. J Clin Invest (1992) 0.84

Anti-CD5 therapy decreases severity of established disease in collagen type II-induced arthritis in DBA/1 mice. Clin Exp Immunol (1994) 0.84

In vitro IgM and IgM rheumatoid factor production in response to Staphylococcus aureus Cowan I and pokeweed mitogen: the contribution of CD5+ (Leu 1) B cells. Clin Exp Immunol (1989) 0.83

Contributions of neutrophils to the adaptive immune response in autoimmune disease. World J Transl Med (2015) 0.83

CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes. Mol Immunol (2009) 0.82

Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med (1999) 0.82

Presence of activated B-1 cells in chronic inflamed gingival tissue. J Clin Immunol (1998) 0.82

Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood. J Immunol (2016) 0.81

Expression of rheumatoid factor associated cross-reactive idiotopes by glandular B cells in Sjögren's syndrome. Clin Exp Immunol (1991) 0.81

Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue. Clin Exp Immunol (1992) 0.81

Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment. J Virol (2004) 0.81

IgM rheumatoid factor in congenital syphilis: associations with clinical and laboratory findings. Clin Exp Immunol (1991) 0.81

A new assay uses monoclonal anti-Rh(D) antibodies to determine rheumatoid factor specificity: reactivity to a monoclonal antibody of the Gm allotype G3m(21) is more frequent in rheumatoid patients negative for G3m(21) Clin Exp Immunol (1988) 0.80

B lymphocytes and humoral immune responses in rheumatoid arthritis. Clin Rheumatol (1995) 0.80

Immunological cells and functions in Gaucher disease. Crit Rev Oncog (2013) 0.80

Phenotype and function of CD25-expressing B lymphocytes isolated from human umbilical cord blood. Clin Dev Immunol (2011) 0.80

Increased numbers of CD5+ B cells and T cell receptor (TCR) gamma delta+ T cells are associated with younger age of onset in rheumatoid arthritis (RA). Clin Exp Immunol (1996) 0.80

Increased CD5-positive B lymphocytes in type I diabetes. Clin Exp Immunol (1991) 0.80

Human hybridomas derived from CD5+ B lymphocytes of patients with chronic lymphocytic leukemia (B-CLL) produce multi-specific natural IgM (kappa) antibodies. Clin Exp Immunol (1991) 0.80

Perspectives on fetal derived CD5(+) B1 B cells. Eur J Immunol (2015) 0.80

Influence of dietary energy restriction on the numbers and proportions of Ly-1+ B lymphocytes in autoimmunity-prone mice. Proc Natl Acad Sci U S A (1989) 0.79

Natural IgM anti-leucocyte autoantibodies (IgM-ALA) regulate inflammation induced by innate and adaptive immune mechanisms. J Clin Immunol (2014) 0.79

The role of interleukin 2 in the regulation of proliferation and IgM synthesis of human newborn mononuclear cells. Clin Exp Immunol (1989) 0.79

Repertoire of CD5+ and CD5- cord blood B cells: specificity and expression of VH I and VH III associated idiotopes. Clin Exp Immunol (1992) 0.79

IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis. Clin Exp Immunol (1992) 0.79

Therapeutic implications of autoantibodies in rheumatoid arthritis. RMD Open (2016) 0.78

Cord blood contains cells secreting antibodies to nervous system components. Clin Exp Immunol (1991) 0.78

Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials. Arthritis Res Ther (2015) 0.78

High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood. Clin Exp Immunol (1995) 0.77

To B or not to B cells-mediate a healthy start to life. Clin Exp Immunol (2013) 0.77

Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease. Front Immunol (2016) 0.77

Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. J Exp Med (2016) 0.77

Molecular determinants of polyreactive antibody binding: HCDR3 and cyclic peptides. Clin Exp Immunol (2000) 0.76

Autoantibodies and antibacterial antibodies: from both sides now. Ann Rheum Dis (1990) 0.76

The bacterial superantigen Staphylococcal enterotoxin B stimulates lymphocyte locomotor capacity during culture in vitro. Immunology (1996) 0.76

Loss of a chromosomal region with synteny to human 13q14 occurs in mouse chronic lymphocytic leukemia that originates from early-generated B-1 B cells. Leukemia (2016) 0.76

Abnormalities in the regulation of variable region genes that encode for antibodies to DNA may be a central factor in the pathogenesis of systemic lupus erythematosus. Ann Rheum Dis (1993) 0.75

Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. Arthritis Res Ther (2016) 0.75

Production of rheumatoid factor in adoptively immune guinea-pigs after challenge with Treponema pallidum. Immunology (1992) 0.75

Asbestos activates CH12.LX B-lymphocytes via macrophage signaling. J Immunotoxicol (2011) 0.75

Low molecular weight IgM and CD5 B lymphocytes in rheumatoid arthritis. Ann Rheum Dis (1994) 0.75

Glomerular lesions induced in the rabbit by physicochemically altered homologous IgG. Am J Pathol (1992) 0.75

Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally. Clin Exp Immunol (1991) 0.75

In vitro IgG rheumatoid factor production by CD5-negative murine B cells in response to immune complexes of lipopolysaccharide. Clin Exp Immunol (1990) 0.75

Suppression of immune system genes by methylprednisolone in exacerbations of multiple sclerosis. Preliminary results. J Neurol (2004) 0.75

The Mechanisms Underlying Chronic Inflammation in Rheumatoid Arthritis from the Perspective of the Epigenetic Landscape. J Immunol Res (2016) 0.75

Major immunoglobulin capping deficiency in the peripheral blood B cells of patients with Sjögren's syndrome. Immunology (1992) 0.75

IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells. Clin Exp Immunol (1993) 0.75

Developmental expression of B cell molecules in equine lymphoid tissues. Vet Immunol Immunopathol (2016) 0.75

Characteristics of submucosal lymphoid tissue located in the proximal colon of the rat. J Anat (1989) 0.75

Premises for immune interventional therapy in rheumatoid arthritis. Postgrad Med J (1988) 0.75

Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells. J Immunol (2016) 0.75

Articles by these authors

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91

Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 10.87

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature (1996) 10.67

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J (1990) 9.17

Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85

Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties. Antimicrob Agents Chemother (1975) 8.67

Pipemidic acid: its activities against various experimental infections. Antimicrob Agents Chemother (1976) 7.92

Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A (1998) 7.69

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature (1998) 7.38

Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08

B cell development pathways. Annu Rev Immunol (2001) 6.94

Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med (2000) 6.68

Essential role of Stat6 in IL-4 signalling. Nature (1996) 6.56

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell (1994) 6.45

Pipemidic acid: absorption, distribution, and excretion. Antimicrob Agents Chemother (1975) 6.38

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity (1994) 6.18

Structure and function of a new STAT-induced STAT inhibitor. Nature (1997) 6.02

The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med (1983) 5.74

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell (1989) 5.72

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci U S A (1987) 5.68

In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob Agents Chemother (1983) 5.45

Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol (1997) 5.38

Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity (1999) 5.34

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum (2006) 5.20

Biological and clinical aspects of interleukin 6. Immunol Today (1990) 5.17

Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J (1990) 5.16

Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 5.15

Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell (1990) 5.06

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science (1988) 4.93

Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol (1998) 4.74

Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity (1998) 4.70

Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J (1997) 4.51

Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res (1986) 4.36

Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell (1995) 4.34

The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med (1988) 4.31

Abdominal fat: standardized technique for measurement at CT. Radiology (1999) 4.25

Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A (1994) 4.25

Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A (1993) 4.23

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol (1988) 4.20

Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med (1985) 4.16

Interleukin-6 in biology and medicine. Adv Immunol (1993) 4.06

IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A (1989) 4.03

Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol (2001) 3.92

Infection with HIV is associated with elevated IL-6 levels and production. J Immunol (1990) 3.89

The chemistry and biology of unusual DNA structures adopted by oligopurine.oligopyrimidine sequences. FASEB J (1988) 3.84

New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity. J Bacteriol (1981) 3.65

Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J (1987) 3.64

Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A (1993) 3.59

The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med (1993) 3.57

Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol (1998) 3.48

Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A (1985) 3.46

Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell (1986) 3.34

Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn (1999) 3.33

Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature (1991) 3.32

Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci U S A (1991) 3.31

Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med (1989) 3.28

Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature (1986) 3.24

IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science (1993) 3.13

Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids. Antimicrob Agents Chemother (1978) 3.12

IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol (2000) 3.08

Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol (1989) 3.01

Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev (1994) 3.00

Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron (1997) 2.93

LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science (1993) 2.93

Positive selection of natural autoreactive B cells. Science (1999) 2.91

Non-invasive quantitative detection and applications of non-toxic, S65T-type green fluorescent protein in living plants. Plant J (1999) 2.88

B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med (1988) 2.88

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res (1996) 2.86

CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell (1992) 2.83

IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev (1992) 2.80

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A (1990) 2.79

Factors affecting B-cell growth and differentiation. Annu Rev Immunol (1985) 2.78

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci U S A (1987) 2.76

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum (2002) 2.75

Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A (1996) 2.70

Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO J (1991) 2.68

STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A (1996) 2.64

Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun (2001) 2.63

Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood (1992) 2.62

Identification of the earliest B lineage stage in mouse bone marrow. Immunity (1996) 2.62

The mechanism of ammonia assimilation in nitrogen fixing Bacteria. Arch Mikrobiol (1971) 2.59

Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys. Antimicrob Agents Chemother (1983) 2.58

Isolation of a factor causing morphological changes of chinese hamster ovary cells from the culture filtrate of Vibrio parahaemolyticus. Infect Immun (1976) 2.56

A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc Natl Acad Sci U S A (1992) 2.55

Sarin poisoning in Matsumoto, Japan. Lancet (1995) 2.52

Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol (2001) 2.51

Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage? Annu Rev Immunol (1988) 2.50

A novel mode of DNA recognition by a beta-sheet revealed by the solution structure of the GCC-box binding domain in complex with DNA. EMBO J (1998) 2.48

T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. J Immunol (1981) 2.46

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett (1989) 2.43

Pharmacokinetics of a novel quinolone, AT-4140, in animals. Antimicrob Agents Chemother (1990) 2.42

Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies. Eur J Immunol (1988) 2.41